T 0860/21 (Multivalent PCV2 composition/BOEHRINGER INGELHEIM) of 20.02.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T086021.20240220
- Date of decision
- 20 February 2024
- Case number
- T 0860/21
- Petition for review of
- -
- Application number
- 06848471.6
- IPC class
- A61K 39/04A61K 39/12A61K 39/295
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Multivalent PCV2 immunogenic compositions
- Applicant name
- Boehringer Ingelheim Animal Health USA Inc.
- Opponent name
- Elanco US Inc.
Intervet International B.V. (opposition withdrawn)
Laboratorios Hipra, S.A. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Inventive step - (no)
Amendment to appeal case - justification by party (no)
Remittal - (no) - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.